We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue

Download Mobile App




In Other News

Synopsis: TMPRSS2-ERG confers resistance of prostate cancer to antiandrogens (Sekar, A., Selvadurai, B.R., Chatterjee, R. et al. EMBO Molecular Medicine (2026). doi.org/10.1038/s44321-026-00423-7)

Molecular Marker Identifies Hormone Therapy Resistance Pathway in Prostate Cancer

Most prostate cancers depend on androgen signaling, making hormone suppression or blockade a central treatment strategy. Read more
14 May 2026 | Molecular Diagnostics
mage: Combining genetic factors with markers of biological ageing could enable a simple blood test to identify dementia risk before symptoms emerge (photo courtesy of Shutterstock)

Blood-Based “Ageing Clock” Helps Predict Dementia Risk and Earlier Onset

Dementia imposes a growing health burden, affecting an estimated 982,000 people in the UK, with cases projected to reach 1. Read more
14 May 2026 | Molecular Diagnostics
Image: Processed on IDS’ random-access automation platforms, the comprehensive portfolio enables direct ChLIA measurement of total testosterone, SHBG, and free testosterone (photo courtesy of Revvity)

FDA-Cleared Assay Enables Comprehensive Automated Testosterone Testing

Accurate evaluation of androgen status often requires concordant measurement of total testosterone, free testosterone, and sex hormone‑binding globulin. Read more
13 May 2026 | Clinical Chem.
Image: Pleiotropic synapse-related genes expressed in peripheral leukocytes of patients with major depressive disorder. The figure summarizes molecular pathways shared between peripheral immune alterations and central synaptic processes in major depressive disorder (Adri, A.S., Nóbile, A.L., de Albuquerque, D.G. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-39284-y)

Gene Signature Shows Promise for Depression Biomarker Testing

Major depressive disorder (MDD) exerts systemic effects that extend beyond mental health, reflecting interplay between the nervous and immune systems. Read more
13 May 2026 | BioResearch
Image: IsoPSA is a blood-based test designed to aid in prostate biopsy decision‑making for men aged 50 years and older with elevated PSA levels (image credit: Shutterstock)

Blood Test Refines Biopsy Decisions in Prostate Cancer

Prostate biopsy decisions remain challenging, with many men undergoing invasive procedures that ultimately yield negative results. Read more
13 May 2026 | Molecular Diagnostics
Image: The platform is built on a foundation model of tumor and immune biology, integrating genomic, transcriptomic, immune, and clinical signals to generate biologically grounded insights (image credit: 123RF)

AI-Driven Tumor Profiling Initiative Targets Precision Therapy Development

Japan faces a significant oncology need, driving efforts to generate clinically relevant data for precision therapies. Read more
13 May 2026 | BioResearch
Image: Schematic overview of the GlycoHBF workflow, from collection of 15 body fluid types to standardized processing and dual-layer proteomic and glycoproteomic profiling (Yong Zhang, CC BY-NC-ND)

Researchers Map Protein and Glycosylation Across 15 Human Body Fluids

Proteins circulating in human body fluids carry valuable signals for health assessment and disease detection. Read more
13 May 2026 | BioResearch
Image: The addition of pTau 217 complements blood-based approaches for clinical decision-making in neurology workflows. The fully automated format supports scalability on the LUMIPULSE G platform (photo courtesty of Shutterstock)

CE-Marked Blood Biomarker Test Advances Automated Alzheimer’s Diagnostics

Specialized care settings frequently evaluate patients aged 50 years and older who present with signs and symptoms of cognitive decline to determine whether amyloid pathology linked to Alzheimer’s disease is present. Read more
13 May 2026 | Clinical Chem.
Image: Graphical Abstract (Jiaming Li, et al. Cell, 2026. doi:10.1016/j.cell.2026.04.025)

Digital Aging Twin Quantifies Biological Aging Across Multiple Organ Systems

Chronological age often fails to capture the wide variability in physiological decline among adults, limiting risk stratification and long-term monitoring. Read more
13 May 2026 | Molecular Diagnostics
Image: Tuberculosis is a leading cause of death among people living with HIV, yet hospital diagnosis remains difficult because symptoms are often non-specific and many patients cannot produce sputum (image credit:123RF)

Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients

Tuberculosis is the leading cause of death among people living with HIV, and diagnosis in hospital settings remains difficult. Read more
13 May 2026 | Microbiology
Image: The findings point to the feasibility of a quick, noninvasive urine-based approach to support earlier decision-making in multiple psychiatric conditions (photo credit: Shutterstock)

Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders

Delays in diagnosing serious psychiatric conditions can leave patients without timely support and complicate treatment planning. Read more
12 May 2026 | Clinical Chem.
Image: The schematic diagram links key MASLD, MASH, and MASLD-HCC molecular drivers to emerging multi‑omics biomarkers and therapeutic modalities, highlighting the current barriers in clinical translation and strategic solutions aimed at refined risk stratification and personalized medicine (Photo courtesy of ©Science China Press)

Emerging Biomarkers Advance Early Detection of MASLD and Liver Cancer Risk

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects about 30% of people worldwide and can advance to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Read more
12 May 2026 | Molecular Diagnostics
Image: The at-home approach combines a finger-prick capillary blood test, returned to a laboratory by mail, with online cognitive assessments completed from home (image credit: 123RF)

At-Home Blood and Cognitive Tests Support Dementia Risk Stratification

Dementia places a substantial burden on patients and health systems, and identifying individuals at elevated risk remains difficult at scale. Read more
12 May 2026 | Clinical Chem.
Image: The patented method serves as the amplification engine within the company’s SeekIt platform, which integrates nucleic acid extraction, amplification, and detection in a portable system (Photo courtesy of Seek Labs)

Patented Isothermal Amplification Chemistry Advances Decentralized Testing

Molecular diagnostics offer high sensitivity for pathogen detection but typically rely on thermal cycling and specialized instruments, limiting their use outside centralized laboratories. Read more
12 May 2026 | Molecular Diagnostics

Channels

Clinical Chemistry

view channel
Routine Blood Tests Years Before Pregnancy Could Identify Preeclampsia Risk
Blood Test Detects Testicular Cancer Missed by Standard Markers
Routine Blood Tests Identify Biomarkers Linked to PTSD
Image: The dSAA method partitions a patient’s cerebrospinal fluid into nanoliter-scale compartments and digitally counts the number of TDP-43 protein “seeds” present under a microscope (image credit: Shutterstock)

Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype

Dementia affects more than 57 million people worldwide and is projected to nearly double within two decades, straining health systems and families. While biomarkers now enable accurate identification of... Read more

Molecular Diagnostics

view channel
Urine Test Beats MRI in Identifying Prostate Cancer Upgrading During Active Surv...
Direct-to-Patient Genetic Testing Identifies Hereditary Cancer Risk in Survivors
Genomic Testing Program Improves Diagnosis of Congenital Hyperinsulinism
Image: Unlike standard tests that detect bacteria directly, host-response assays measure the body\'s immune response, potentially enabling earlier infection detection and risk identification (image credit: Adobe Stock)

Finger-Prick Blood Test Aids Early Tuberculosis Detection and Risk Stratification

Household contacts of people with tuberculosis face an estimated 2% risk of developing disease, yet most are asymptomatic at the time of screening. Early-stage cases are often missed because symptom checks... Read more

Hematology

view channel
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Blood Test Enables Early Detection of Multiple Myeloma Relapse
Single Assay Enables Rapid HLA and ABO Genotyping for Transplant Matching
Image: Graphical abstract (Waclawiczek A, Leppä AM, Renders S, et al. Cell Stem Cell, 2026. doi:10.1016/j.stem.2026.04.012)

Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read more

Immunology

view channel
Point-of-Care Tests Could Expand Access to Mpox Diagnosis
T-Cell Senescence Profiling May Predict CAR T Responses
Finger-Prick Lateral Flow Test Detects Sepsis Biomarkers at Point of Care
Image: Modern diagnostic tools can pinpoint the specific allergenic proteins driving a patient’s sensitization, helping distinguish true allergy from cross-reactivity (image credit: Adobe Stock)

Biomarkers and Molecular Testing Advance Precision Allergy Care

Allergic diseases often present with similar symptoms but can be driven by distinct biological mechanisms, making standardized care inefficient for many patients. Historically, individuals with pollen... Read more

Microbiology

view channel
Oral–Gut Microbiome Signatures Identify Early Gastric Cancer
Label-Free Microscopy Method Enables Faster, Quantitative Detection of Malaria
Gut Microbiome Test Predicts Melanoma Recurrence After Surgery
Image: Biosensor for tuberculosis detection (photo courtesy of UPV)

Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour

Tuberculosis remains a major global health challenge and continues to drive significant morbidity and mortality. The World Health Organization’s 2024 global report cites it as the leading cause of death... Read more

Pathology

view channel
New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
AI System Analyzes Routine Pathology Slides to Predict Cancer Outcomes
New Tissue Mapping Approach Identifies High-Risk Form of Diabetic Kidney Disease
Image: ArteraAI Breast analyzes digitized histopathology images alongside patient clinical variables to produce an AI-derived risk score that provides prognostic insight into the likelihood of distant metastasis (Image credit: Adobe Stock)

FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification

Risk assessment at diagnosis is central to guiding therapy for early-stage, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) invasive breast cancer, where overtreatment... Read more

Technology

view channel
Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
New Platform Captures Extracellular Vesicles for Early Cancer Detection
Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
Image: The fully automated workflow builds on growing adoption of LIAISON QuantiFERON‑TB Gold Plus II (photo courtesy of Diasorin)

Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing

Latent tuberculosis remains a substantial testing workload for clinical laboratories as screening programs expand. Despite this growth, only about 40% of testing has shifted from traditional skin tests... Read more

Industry

view channel
FDA Clears Blood-Based Companion Diagnostic for Advanced Breast Cancer Therapy
CareDx Expands Precision Oncology Portfolio with Naveris Acquisition
Thermo Fisher Scientific to Sell Microbiology Business to Astorg
Image:The transaction is expected to close in the second half of 2026, with Roche paying USD 750 million upfront and up to USD 300 million in additional milestone payments

Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio

Roche has entered into a definitive merger agreement to acquire PathAI, a company focused on digital pathology and artificial intelligence for pathology laboratories and the biopharma industry.... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica ADLM

 

Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC ECCMID
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE